Key result
Ribosomal E site enters the third stage of scientific acceptance as important but not new.
Key points are not available for this paper at this time.
Ribosomal E site acceptance as established may standardize models; leaves open its dynamic roles in translation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Blaha et al. (2001) studied this question. The ribosomal E site is transitioning toward the third stage of scientific acceptance, where it is recognized as important but not new.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: